1
|
Banerjee T, Crews DC, Tuot DS, Pavkov ME, Burrows NR, Stack AG, Saran R, Bragg-Gresham J, Powe NR. Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension. Kidney Int 2019; 95:1433-1442. [PMID: 30975440 DOI: 10.1016/j.kint.2018.12.027] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Revised: 12/07/2018] [Accepted: 12/20/2018] [Indexed: 02/07/2023]
Abstract
The Dietary Approaches to Stop Hypertension (DASH) diet lowers blood pressure, an important risk factor for chronic kidney disease (CKD) and end-stage renal disease (ESRD). However, it is unclear whether adherence to a DASH diet confers protection against future ESRD, especially among those with pre-existing CKD and hypertension. We examined whether a DASH diet is associated with lower risk of ESRD among 1,110 adults aged ≥ 20 years with hypertension and CKD (estimated glomerular filtration rate, eGFR 30-59 ml/min/1.73 m2) enrolled in the National Health and Nutrition Examination Survey (1988-1994). Baseline DASH diet accordance score was assessed using a 24-hour dietary recall questionnaire. ESRD was ascertained by linkage to the U.S. Renal Data System registry. We used the Fine-Gray competing risks method to estimate the relative hazard (RH) for ESRD after adjusting for sociodemographics, clinical and nutritional factors, eGFR, and albuminuria. Over a median follow-up of 7.8 years, 18.4% of subjects developed ESRD. Compared to the highest quintile of DASH diet accordance, there was a greater risk of ESRD among subjects in quintiles 1 (RH=1.7; 95% CI 1.1-2.7) and 2 (RH 2.2; 95% CI 1.1-4.1). Significant interactions were observed with diabetes status and race/ethnicity, with the strongest association between DASH diet adherence and ESRD risk observed in individuals with diabetes and in non-Hispanic blacks. Low accordance to a DASH diet is associated with greater risk of ESRD in adults with moderate CKD and hypertension, particularly in non-Hispanic blacks and persons with diabetes.
Collapse
Affiliation(s)
- Tanushree Banerjee
- Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, California, USA.
| | - Deidra C Crews
- Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
| | - Delphine S Tuot
- Division of Nephrology, Department of Medicine, University of California, San Francisco, California, USA
| | - Meda E Pavkov
- Division of Diabetes Translation, Centers of Disease and Control and Prevention, Atlanta, Georgia, USA
| | - Nilka Rios Burrows
- Division of Diabetes Translation, Centers of Disease and Control and Prevention, Atlanta, Georgia, USA
| | - Austin G Stack
- Department of Nephrology and Internal Medicine, University Hospital Limerick, Limerick, Ireland
| | - Rajiv Saran
- Kidney Epidemiology & Cost Center, University of Michigan, Ann Arbor, Michigan, USA; Division of Nephrology, Department of Medicine and Kidney Epidemiology & Cost Center, University of Michigan, Ann Arbor, Michigan, USA
| | | | - Neil R Powe
- Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, California, USA; Department of Medicine, Zuckerberg San Francisco General Hospital, San Francisco, California, USA
| | | |
Collapse
|
2
|
Abstract
Cystinuria is a genetic disease that leads to frequent formation of stones. In patients with recurrent stone formation, particularly patients <30 years old or those who have siblings with stone disease, urologists should maintain a high index of suspicion of the diagnosis of cystinuria. Patients with cystinuria require frequent follow-up and a multidisciplinary approach to diagnosis, prevention and management. Patients have reported success in preventing stone episodes by maintaining dietary changes using a tailored review from a specialist dietician. For patients who do not respond to conservative lifestyle measures, medical therapy to alkalinize urine and thiol-binding drugs can help. A pre-emptive approach to the surgical management of cystine stones is recommended by treating smaller stones with minimally invasive techniques before they enlarge to a size that makes management difficult. However, a multimodal approach can be required for larger complex stones. Current cystinuria research is focused on methods of monitoring disease activity, novel drug therapies and genotype-phenotype studies. The future of research is collaboration at a national and international level, facilitated by groups such as the Rare Kidney Stone Consortium and the UK Registry of Rare Kidney Diseases.
Collapse
|
3
|
Fleischmann R, Kerr B, Yeh LT, Suster M, Shen Z, Polvent E, Hingorani V, Quart B, Manhard K, Miner JN, Baumgartner S. Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia. Rheumatology (Oxford) 2014; 53:2167-74. [PMID: 24509406 DOI: 10.1093/rheumatology/ket487] [Citation(s) in RCA: 79] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
OBJECTIVE The aim of this study was to evaluate the pharmacodynamics (PDs), pharmacokinetics (PKs) and safety of lesinurad (selective uric acid reabsorption inhibitor) in combination with febuxostat (xanthine oxidase inhibitor) in patients with gout. METHODS This study was a phase IB, multicentre, open-label, multiple-dose study of gout patients with serum uric acid (sUA) >8 mg/dl following washout of urate-lowering therapy with colchicine flare prophylaxis. Febuxostat 40 or 80 mg/day was administered on days 1-21, lesinurad 400 mg/day was added on days 8-14 and then lesinurad was increased to 600 mg/day on days 15-21. sUA, urine uric acid and PK profiles were evaluated at the end of each week. Safety was assessed by adverse events, laboratory tests and physical examinations. RESULTS Initial treatment with febuxostat 40 or 80 mg/day monotherapy resulted in 67% and 56% of subjects, respectively, achieving a sUA level <6 mg/dl. Febuxostat 40 or 80 mg/day plus lesinurad 400 or 600 mg/day resulted in 100% of subjects achieving sUA <6 mg/dl and up to 100% achieving sUA <5 mg/dl. No clinically relevant changes in the PKs of either drug were noted. The combination was well tolerated. CONCLUSION The clinically important targets of sUA <6 mg/dl and <5 mg/dl are achievable in 100% of patients when combining lesinurad and febuxostat.
Collapse
Affiliation(s)
- Roy Fleischmann
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA.
| | - Bradley Kerr
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Li-Tain Yeh
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Matt Suster
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Zancong Shen
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Elizabeth Polvent
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Vijay Hingorani
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Barry Quart
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Kimberly Manhard
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | - Jeffrey N Miner
- Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA
| | | | | |
Collapse
|
5
|
Abstract
In recent years stone disease has become more widespread in developed countries. At present the prevalence is 5.2 and 15% of men and 6% of women are affected. The increase is linked to changes in lifestyle, eating patterns and obesity which has become very common. The 'metabolic syndrome' includes all the diseases, e.g. hypertension, lipid imbalances, type 2 diabetes mellitus, gout and cardiovascular disease, which are concomitant in the majority of stone formers. Dietary patterns, besides leading to stone formation, also determine stone chemistry. With a diet that is rich in oxalates, calcium oxalate will constitute 75% of stones, struvite 10-20%, uric acid 5-6% and cystine 1%. As approximately 50% of patients with stones suffer recurrences, metabolic and/or pharmacological prophylaxis is recommended.
Collapse
Affiliation(s)
- M Porena
- Department of Urology and Andrology, University of Perugia, Perugia, Italy.
| | | | | |
Collapse
|
6
|
Remer T, Dimitriou T, Manz F. Dietary potential renal acid load and renal net acid excretion in healthy, free-living children and adolescents. Am J Clin Nutr 2003; 77:1255-60. [PMID: 12716680 DOI: 10.1093/ajcn/77.5.1255] [Citation(s) in RCA: 238] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND There is increasing evidence that acid-base status has a significant effect on high-intensity physical performance, urolithiasis, and calcium metabolism. Experimental studies in adults showed that renal net acid excretion (NAE) can be reliably estimated from the composition of diets. OBJECTIVE We investigated whether a reasonable estimation of NAE is also possible from the dietary records of free-living children and adolescents. DESIGN Healthy children (aged 8 y; n = 165) and adolescents (aged 16-18 y; n = 73) each collected a 24-h urine sample and completed a weighed diet record on the same day. Urinary NAE was analyzed (NAE(an)) and estimated (NAE(es)). Potential renal acid load (PRAL), the diet-based component of NAE(es), corrects for intestinal absorption of ingested minerals and sulfur-containing protein. A urinary excretion rate of organic acids (OAs) proportional to body surface area was assumed for the complete estimate (NAE(es) = PRAL + OA(es)). RESULTS Significant (P < 0.001) correlations between NAE(es) and NAE(an) were seen in the children (r = 0.43) and the adolescents (r = 0.51). A simplified estimate based on only 4 components of dietary PRAL (protein, phosphorus, potassium, and magnesium) yielded almost identical associations. Mean simplified NAE(es) (32.6 +/- 13.9 and 58.4 +/- 22.0 mEq/d in the children and the adolescents, respectively) agreed reasonably with NAE(an) (32.4 +/- 15.5 and 52.8 +/- 24.3 mEq/d, respectively). CONCLUSIONS Predicting NAE from dietary intakes, food tables, and anthropometric data is also applicable during growth and yields appropriate estimates even when self-selected diets are consumed. The PRAL estimate based on only 4 nutrients may allow relatively simple assessment of the acidity of foods and diets.
Collapse
Affiliation(s)
- Thomas Remer
- Department of Nutrition and Health, the Research Institute of Child Nutrition, Dortmund, Germany.
| | | | | |
Collapse
|
7
|
Abstract
Kidney stones can form during a state of urinary supersaturation. Because urine often is supersaturated with respect to various salts, crystal formation is very common in nonstone formers and stone formers alike, and it may even be absent in kidney stone formers. Thus, uncomplicated crystalluria does not distinguish between stone formers and healthy people. Landmark clinical studies, however, have shown that under identical conditions of dietary and fluid intake, healthy controls almost exclusively excrete single calcium oxalate crystals 3 to 4 microns in diameter, whereas recurrent calcium stone formers pass larger crystals, 10 to 12 microns in diameter, often fused into polycrystalline aggregates 20 to 300 microns in diameter. Thus, those who form stones appear to be more "sensitive" to a given diet than nonstone formers. It is in these subjects that "bad dietary habits" induce nephrolithiasis, making nutritional aspects important. This article reviews the current evidence-based knowledge of the impact of nutrition on the recurrence of a kidney stone.
Collapse
Affiliation(s)
- Bernhard Hess
- Departments of Internal Medicine and Nephrology, Hospital Zimmerberg, CH-8820 Waedenswil, Switzerland.
| |
Collapse
|